Speaker Profile
Mary Hamby

Mary Hamby PhD

Neurology
Houston, Texas, United States of America

Connect with the speaker?

Mary Hamby, PhD, joined the Neurodegeneration Consortium at MD Anderson in February 2016, where she leads the neuroinflammation drug discovery efforts towards the goal of discovering novel therapeutics for Alzheimer’s disease. Previously, Dr. Hamby was a neuroinflammation specialist at Lundbeck within the neuroinflammation division focused on targeting microglia for several CNS disorders including Alzheimer’s disease. Prior to entering the drug discovery space, Dr. Hamby did a postdoctoral fellowship in glial biology and neuroinflammation at the University of California, Los Angeles.
Dr. Hamby earned her PhD in Biomedical Science at the University of Connecticut, where her research focused on understanding the differential regulation of astrocyte and microglial gene expression by inflammatory mediators.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)